Gerd Rippin. Which Marginal Estimator to Apply for External Comparator Studies: The ATT, ATE, ATU, or ATO?. // Pharmacoepidemiology and Drug Safety. – 2026. – DOI: 10.1002/pds.70523. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pds.70523?af=R
Gerd Rippin (2026). Which Marginal Estimator to Apply for External Comparator Studies: The ATT, ATE, ATU, or ATO?. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70523
Gerd Rippin. “Which Marginal Estimator to Apply for External Comparator Studies: The ATT, ATE, ATU, or ATO?.” Pharmacoepidemiology and Drug Safety, 2026. doi:10.1002/pds.70523.
@article{Rippin2026,
title = {Which Marginal Estimator to Apply for External Comparator Studies: The ATT, ATE, ATU, or ATO?},
author = {Rippin, Gerd},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
doi = {10.1002/pds.70523},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pds.70523?af=R}
}